p53-independent functions of MDM2

被引:0
|
作者
Ganguli, G [1 ]
Wasylyk, B [1 ]
机构
[1] ULP, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The tumor suppressor p53 is inactivated by overexpression of MDM2 in about 10% of human tumors. However, p53 is inactivated by other mechanisms in the majority of tumors, raising the possibility that MDM2 may be irrelevant to transformation in most cases. However, MDM2 has been reported to have p53-independent functions, in cell cycle control, differentiation, cell fate determination, DNA repair, basal transcription, and other processes. Furthermore, MDM2 appears to contribute to the transformed phenotype in the absence of wild-type p53. Nevertheless, the number of studies is still limited, and the evidence in some cases does not unequivocally show that the functions are p53 independent. We will discuss the circuits of regulation involving MDM2 that do not directly concern p53. Hopefully, future work will consolidate our understanding of the p53-independent pathological functions of MDM2 and will lead to useful therapeutic interventions that target the majority of tumors.
引用
收藏
页码:1027 / 1035
页数:9
相关论文
共 50 条
  • [1] Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis
    Jones, SN
    Hancock, AR
    Vogel, H
    Donehower, LA
    Bradley, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) : 15608 - 15612
  • [2] Novel MDM2 p53-independent functions identified through RNA silencing technologies
    Zhang, Z
    Wang, H
    Li, M
    Rayburn, E
    Agrawal, S
    Zhang, RW
    [J]. THERAPEUTIC OLIGONUCLEOTIDES: TRANSCRIPTIONAL AND TRANSLATIONAL STRATEGIES FOR SILENCING GENE EXPRESSION, 2005, 1058 : 205 - 214
  • [3] p53-independent activities of MDM2 and their relevance to cancer therapy
    Zhang, Z
    Zhang, RW
    [J]. CURRENT CANCER DRUG TARGETS, 2005, 5 (01) : 9 - 20
  • [4] MDM2 promotes p53-independent breast cancer metastatic phenotypes
    Gao, Chong
    Kundu, Nandini
    Bargonetti, Jill
    [J]. CANCER RESEARCH, 2015, 75
  • [5] p53-independent role of MDM2 in TGF-β1 resistance
    Sun, PQ
    Dong, P
    Dai, K
    Hannon, GJ
    Beach, D
    [J]. SCIENCE, 1998, 282 (5397) : 2270 - 2272
  • [6] Mdm2 binds to and inhibits Nbs1 in a p53-independent manner
    Bouska, Alyssa C.
    Eischen, Christine M.
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [7] An alternative splice form of Mdm2 induces p53-independent cell growth and tumorigenesis
    Steinman, HA
    Burstein, E
    Lengner, C
    Gosselin, J
    Pihan, G
    Duckett, CS
    Jones, SN
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (06) : 4877 - 4886
  • [8] CHROMATIN-BOUND MDM2 PLAYS A p53-INDEPENDENT ROLE IN TUMOR METABOLISM
    不详
    [J]. CANCER DISCOVERY, 2016, 6 (07) : 693 - 693
  • [9] MDM2 mediates fibroblast activation and renal tubulointerstitial fibrosis via a p53-independent pathway
    Ye, Chen
    Tang, Hui
    Zhao, Zheng
    Lei, Chun-Tao
    You, Chao-Qun
    Zhang, Jiao
    Gao, Pan
    He, Fang-Fang
    Chen, Shan
    Wang, Yu-Mei
    Zhang, Chun
    Su, Hua
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2017, 312 (04) : F760 - F768
  • [10] MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation
    D-L Qi
    D Cobrinik
    [J]. Oncogene, 2017, 36 : 1760 - 1769